AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201,172,847 | +29.7% | 3,977,320 | +19.8% | 0.01% | +50.0% |
| Q2 2023 | $155,064,633 | +45.6% | 3,321,153 | +19.3% | 0.00% | +33.3% |
| Q1 2023 | $106,492,004 | -29.6% | 2,783,377 | +0.9% | 0.00% | -40.0% |
| Q4 2022 | $151,167,390 | +89.3% | 2,758,529 | +17.6% | 0.01% | +66.7% |
| Q3 2022 | $79,864,000 | +304.1% | 2,345,477 | +12.2% | 0.00% | +200.0% |
| Q2 2022 | $19,763,000 | -26.5% | 2,091,241 | +10.3% | 0.00% | 0.0% |
| Q1 2022 | $26,896,000 | -34.6% | 1,895,528 | -2.5% | 0.00% | 0.0% |
| Q4 2021 | $41,119,000 | -1.4% | 1,944,122 | +4.2% | 0.00% | 0.0% |
| Q3 2021 | $41,716,000 | -9.0% | 1,866,557 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $45,844,000 | +7.9% | 1,847,848 | +26.1% | 0.00% | 0.0% |
| Q1 2021 | $42,497,000 | +22.3% | 1,464,818 | +8.8% | 0.00% | 0.0% |
| Q4 2020 | $34,750,000 | -16.6% | 1,346,904 | -0.5% | 0.00% | -50.0% |
| Q3 2020 | $41,681,000 | +62.4% | 1,353,758 | +31.4% | 0.00% | +100.0% |
| Q2 2020 | $25,667,000 | +68.1% | 1,029,982 | +43.0% | 0.00% | 0.0% |
| Q1 2020 | $15,267,000 | +27.4% | 720,114 | +33.4% | 0.00% | – |
| Q4 2019 | $11,983,000 | +71.1% | 539,899 | +75.4% | 0.00% | – |
| Q3 2019 | $7,005,000 | +150.4% | 307,856 | +110.6% | 0.00% | – |
| Q2 2019 | $2,798,000 | – | 146,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |